Eleison Pharmaceuticals Inc. (ELSN)

Eleison Pharmaceuticals was planning to go public, but the IPO was withdrawn on Jun 29, 2023.

Stock Price: Pending

IPO price not available yet

Eleison Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2020	2019
Debt / Equity Ratio	1.17	0.31	-0.34
Debt / EBITDA Ratio	-0.16	-0.14	-12.74
Debt / FCF Ratio	-0.06	-0.08	-4.57
Quick Ratio	1.63	1.62	0.00
Interest Coverage	-14.08	-2.81	-0.34
Return on Equity (ROE)	-905.62%	-330.39%	12.93%
Return on Assets (ROA)	-	-98.80%	-2823.03%
Return on Capital (ROIC)	-153.36%	-23.48%	5.02%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).